An open-label evaluation of the tolerability and safety of Stalevo® (carbidopa, levodopa and entacapone) in Parkinson’s disease patients experiencing wearing-off
- 22 October 2004
- journal article
- clinical trial
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 112 (2) , 221-230
- https://doi.org/10.1007/s00702-004-0184-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: